Patrick Hautecœur

Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)

William Camu, Philippe Lehert, Charles Pierrot‐Deseilligny et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion

Gauthier Calais, G Forzy, C. Crinquette et al. · Multiple Sclerosis Journal · 2009 · 55 citations

Medicine, Neurology, Diagnostic Imaging +10

Social participation in patients with multiple sclerosis: correlations between disability and economic burden

Arnaud Kwiatkowski, Jean-Pierre Marissal, Madani Pouyfaucon et al. · BMC Neurology · 2014 · 49 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients

Floriane Calocer, Olivier Dejardin, Arnaud Kwiatkowski et al. · Multiple Sclerosis and Related Disorders · 2020 · 49 citations · Full text

Social Sciences, Community Health, Disability +13

Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study

Laure Peyro‐Saint‐Paul, Christian Créveuil, Olivier Heinzlef et al. · Journal of the Neurological Sciences · 2016 · 46 citations

Medicine, Neurology, Pharmacology +17